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It has been well established in the literature that the cribriform-morular variant of papillary thyroid carcinoma (CMVPTC) has
been observed with higher frequency in familial adenomatous polyposis (FAP) patients. In the usual setting, patients with FAP are
identiﬁed based on their germline mutations and the diagnosis of thyroid neoplasm is made after the FAP diagnosis. We herein
report a case in which the recognition of a CMVPTC led to the initial diagnosis of FAP. The histological and clinical features of
CMVPTC are reviewed with emphasis on its relationship to FAP.
1.Introduction
Thyroid neoplasms occur in patients with familial adeno-
matous polyposis (FAP) with a frequency reported to be
increased to as much as 100–160 times the rate seen in the
general population [1, 2]. Harach et al. [3], in a report of 28
tumors in 4 patients with FAP, were the ﬁrst to recognize and
describe in detail the unusual morphology of these tumors.
They suggested that FAP-associated thyroid tumors have
similarities to typical papillary thyroid carcinoma (PTC),
but are suﬃciently unique that they should be considered a
tumor distinct from both follicular and papillary carcinoma.
There are two reported cases in the literature of recognition
of this unusual thyroid neoplasm leading to the diagnosis
of familial polyposis [4]; sporadic counterparts, non FAP
associated, have been described as well [5]. We herein
describe a case of diagnosis of FAP in an individual without
a family history of colonic disease based on recognition of a
thyroid neoplasm of unusual morphology.
2.CaseReport
A 23-year-old Chinese woman underwent total thyroidec-
tomy for a painless enlargement of the thyroid gland. The
enlargementhadﬁrstbeennoted10yearspriortoadmission,
and there had been a gradual increase in size during the
intervening period. The patient had no family history of
colorectal cancer and both parents were in good health.
She did not have any gastrointestinal symptoms and was
otherwise well. A total thyroidectomy was performed for a
clinical diagnosis of nodular goitre.
On the basis of the thyroid pathology, a ﬂexible sig-
moidoscopy was performed. This revealed numerous small
(<5mm) polyps scattered in clusters from rectum to
descending colon. Biopsies of these polyps showed that
they were all tubular adenomas. At colonoscopy there were
more than 100 small polyps throughout the colon but
predominantly left-sided. There were no polyps found on
esophagogastroduodenoscopy. DNA extracted from blood
lymphocytes showed a truncating mutation in segment 1 of
the APC gene by protein truncation analysis, conﬁrming the
diagnosis of FAP. A total colectomy was performed.
One year following colectomy, two ﬁrm, immobile intra-
abdominal masses were noted on physical examination. An
ultrasounddirectedbiopsyofthemassesrevealedﬁbromato-
sis.2 Case Reports in Medicine
Table 1: Antibody information.
Antibody Clone Manufacturer Retrieval Dilution
Thyroglobulin A0251 Dako Heat 1:10.000
EMA E29 Dako Heat 1:200
Cam 5.2 349205 BD Protease 1:50
Cytokeratin 7 OV-TL 12/30 Dako Protease 1:200
Beta-catenin Monocl. mouse (IgG) Cell Marque Protease 1:100
Keratin Cocktail
(i) AE1/AE3 Monocl. mouse Dako Protease 1:200
(ii) CK wide spectrum screen Rabbit anticow Dako Protease 1:1000
(iii) Cam 5.2 349205 BD Protease 1:50
Dako, Mississauga, ON; BD Bioscience, Mississauga, ON; Cell Marque, Rocklin, CA.
3.MaterialsandMethods
The thyroidectomy specimen was ﬁxed in formalin, and
representative paraﬃn-embedded sections were routinely
stained with hematoxylin and eosin. Immunohistochemical
staining was performed with the labelled streptovidin-
biotin-peroxidase detection system using a panel of antibod-
ies (see Table 1).
3.1. Pathology. The excised thyroid weighed 72g and con-
tained one nodule (5 × 4 × 4cm) in the right lobe and three
nodules in the left lobe ranging in size from 0.6 × 0.6 × 0.5
to 3 × 2.5 × 2.0cm.
Light microscopic examination revealed that the three
nodules in the left lobe were surrounded by ﬁbrous capsules
of varying thickness. The architectural patterns within the
nodules were variable, but papillae were present at least
focally in each tumor. The papillae were generally short and
blunt with edematous cores. A prominent ﬁnding within
all of the nodules were cribriform structures composed of
follicles deﬁcient in colloid and lined by ﬂattened to low
cuboidal epithelial cells with scant intervening ﬁbrous tissue
(Figure 1). Other portions of the tumor nodules had a
trabecular arrangement of tall columnar cells. Frequently
within these trabecular areas and to a lesser extent elsewhere,
there were small whorls of cells (Figure 1(c)). The tumor
cell nuclei were oval and overlapping with irregular outlines.
Nuclear grooves were readily identiﬁed and occasional typi-
cal intranuclear cytoplasmic pseudoinclusions were present.
Many of the cells within the whorls had nuclei with a pale
eosinophilic to clear appearance (Figure 1(c)). There was no
necrosis or mitotic activity present.
Immunohistochemical studies showed that the tumor
cells were weakly positive for thyroglobulin (Figure 1(a)
inset) and EMA and strongly positive for keratin, CAM
5.2, and CK7. Beta-catenin immunostaining demonstrated
nuclear localization within the tumor cells (Figure 1(b)
inset). There was no cytoplasmic reactivity for CK20, chro-
mogranin, or S100. In all of the immunostained sections,
including the negative controls, there was strong positivity
within the tumor cell nuclei with the peculiar nuclear
clearing described above.
Microscopic examination showed that the mass in the
right lobe was a follicular adenoma.
4. Discussion
The extraintestinal associations of familial adenomatous
polyposis (FAP) are wellknown and include osteomas,
epidermoid cysts, ﬁbromatosis, adrenal, biliary, liver, and
brain neoplasms (some kindreds with Turcot’s syndrome)
[4]a sw e l la st h y r o i dc a r c i n o m a s[ 2, 6]. The risk of
development of thyroid carcinoma in FAP is not known with
certainty. A report from a large FAP registry indicated that
1.2% of aﬀected individuals develop thyroid carcinomas [7].
Two large studies of FAP patients found a relative risk of
developingthyroidcarcinomaof7.6[8]and23[4]compared
to the general population. However, amongst females with
polyposis, the risk has been estimated at 100–160 times
greater than expected in the general population [1, 2]. Some
authors have recommended that FAP patients be screened
for the development of thyroid carcinoma [1, 2], but this is
controversial [7].
The FAP-associated thyroid tumors reported in the liter-
ature have been variably diagnosed as papillary, follicular, or
mixed papillary and follicular carcinomas [3]. Harach et al.
[3] reported four cases of thyroid carcinoma in FAP patients
with a review of the literature and noted the following
unusual features:
( 1 )f e m a l e : m a l er a t i oo f8 : 1( 2 : 1t o4 : 1i ns p o r a d i c
PTC);otherstudieshavefoundanevenmorestriking
female predominance (f:m—17:1) for this particu-
lar subtye [9, 10],
(2) majority under age 30 ( most in 30–50 age group in
sporadic PTC),
(3) multifocality (diﬀering from sporadic PTC multifo-
cality-tumors encapsulated, circumscribed, diﬀering
architectural patterns), and
(4) unusual histologic patterns: cribriform, solid, spin-
dling, and whorls.Case Reports in Medicine 3
(a) (b)
(c) (d)
Figure 1: Histological features of CMV variant of PTC. Representative pictures of the tumour show the cribriform structures composed
of follicles deﬁcient in colloid and lined by ﬂattened to low cuboidal epithelial cells with scant intervening ﬁbrous tissue (a). The tumor
cells were weakly positive by immunohistochemistry for thyroglobulin ((a)-inset), but showed nuclear localization with immunostaining for
beta-catenin ((b)-inset). Other portions of the tumor nodules had a trabecular arrangement (b, c) of tall columnar cells with small whorls
of cells (arrowheads). The cells within the whorls had nuclei with a pale eosinophilic to clear appearance (c). A minor papillary component
was present within the periphery of the tumor nodule (d). The tumor cell nuclei were oval and overlapping with irregular outlines. Nuclear
grooves were readily identiﬁed and occasional typical intranuclear cytoplasmic pseudoinclusions were present. Magniﬁcation bar: (a) ×40,
(b & d) ×100, and (c) ×200.
The authors concluded that FAP-associated thyroid carcino-
mas were likely related to PTC, but were suﬃciently diﬀerent
to warrant status as a distinct entity.
Based on the distinct and unusual morphology of the
thyroid tumors occurring in FAP patients, Harach et al.
[3] suggested that the recognition of such a tumor should
prompt investigation for FAP. The investigation in the case
reported herein led to a diagnosis of FAP, supporting their
recommendation.
However, Cameselle-Teijeiro and Chan [11]d e s c r i b e d
4 cases with similar or identical morphology apparently
occurring in patients without FAP. Others [5, 12] have also
described similar tumors, again in patients without evidence
of FAP. These tumors have been termed the “cribriform-
morular” variant of PTC (CMV PTC) by Cameselle-Teijeiro
and Chan in recognition of their two most prominent and
unusual patterns. The cribriform areas are composed of
anastomosing bars and arches of cells without intervening
stroma with the follicular spaces devoid of colloid. The
morulas are composed of spindled cells with “peculiar
nuclear clearing.” These clear nuclei diﬀer from both the
optically clear nuclei and intranuclear pseudoinclusions
more typically seen in PTC and consist of accumulations of
biotin [11].
Harach et al. [3] speculated that the morphology of this
apparently distinctive tumor might be related to the involve-
ment of the APC gene in the pathogenesis. Several groups
have analyzed APC gene mutations. Cetta et al. [13]a n a l y z e d
four tumors from patients with known germline APC
mutations. They found no examples of biallelic inactivation.
Soravia et al. [14] studied 9 samples from 4 tumors and
found somatic APC mutation in 1 sample. However, Iwama
et al. [15] found germline and somatic mutation of APC
gene in 2 cases of FAP-associated thyroid carcinomas. These
ﬁndings suggest that, although somatic mutation of APC
gene may be seen in some cases of FAP-associated thyroid
carcinoma, it is not a required step in the pathogenesis of
these neoplasms. However, a number of studies [13, 14,
16] have shown evidence of ret/PTC-1 oncogene activation,
which is known to be an early molecular event in papillary4 Case Reports in Medicine
thyroid carcinoma oncogenesis. This ﬁnding would support
the concept that FAP-associated thyroid tumors are variants
of PTC.
More recently Xu et al. [17] have demonstrated that
aberrant nuclear accumulation of mutant beta-catenin may
substitute for APC mutations in a subset of CMV of PTC
(see Figure 1). It is thought that these sporadic cases are due
to a somatic mutation in exon 3 of the beta-catenin gene
(CTNNB1), further highlighting the analogous role to the
APC-beta-catenin pathway. Although only a small number
of cases have been studied, the most common carcinogenic
genetic abnormality in papillary thyroid carcinoma—BRAF
mutation—appears to be absent in FAP-associated thyroid
cancer [18].
Thyroid carcinomas occurring in FAP patients have
unusual clinical and pathological features, but morphologic
and molecular evidence supports the concept that these are
variants of PTC. Although the morphologic features are
unusual and rarely seen in sporadic PTC, recent reports have
emphasized that they are not speciﬁc for FAP. Nevertheless,
they are suﬃciently uncommon that their presence in a
thyroid tumor should prompt investigation for FAP. This
may be particularly important in the 20% of patients with
FAP who have no family history [6].
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